New and novel antidotes in pediatrics

Area of Science:

• Pediatric Emergency Medicine
• Toxicology
• Pharmacology

Background:

• Antidotal therapy is crucial for managing pediatric poisoning cases.
• While supportive care is often adequate, specific antidotes can drastically decrease illness and death.
• Pediatric emergency medicine practitioners require up-to-date knowledge on antidote use.

Purpose of the Study:

• To review the pediatric applications and constraints of established and novel antidotes.
• To inform practitioners about indications, dosages, administration, and contraindications for critical antidotes.

Main Methods:

• Literature review of current and emerging antidotes used in pediatric poisoning.
• Focused discussion on intravenous N-acetylcysteine, octreotide, crotaline Fab antivenom, fomepizole, atropine, and pralidoxime autoinjectors.
• Inclusion of emerging antidotes with preliminary data.

Main Results:

• Established antidotes like N-acetylcysteine and fomepizole have defined roles in pediatric toxicology.
• Crotaline Fab antivenom, atropine, and pralidoxime autoinjectors are vital for specific envenomations and poisonings.
• Newer antidotes show promise but require further investigation for pediatric use.

Conclusions:

• Familiarity with pediatric antidote indications, administration, and contraindications is essential for emergency physicians.
• A range of specific antidotes are available and effective in reducing morbidity and mortality in poisoned children.
• Ongoing research into novel antidotes will expand treatment options for complex pediatric poisoning cases.